[go: up one dir, main page]

YU46213B - Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata - Google Patents

Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Info

Publication number
YU46213B
YU46213B YU118987A YU118987A YU46213B YU 46213 B YU46213 B YU 46213B YU 118987 A YU118987 A YU 118987A YU 118987 A YU118987 A YU 118987A YU 46213 B YU46213 B YU 46213B
Authority
YU
Yugoslavia
Prior art keywords
formula
hydrogen
amino
group
defined above
Prior art date
Application number
YU118987A
Other languages
English (en)
Other versions
YU118987A (en
Inventor
H. Yamashita
M. Oka
J. Okimura
T. Naito
Original Assignee
Bristol-Myers Squibb Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Co. filed Critical Bristol-Myers Squibb Co.
Priority to YU118987A priority Critical patent/YU46213B/sh
Publication of YU118987A publication Critical patent/YU118987A/xx
Publication of YU46213B publication Critical patent/YU46213B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

POSTUPAK ZA DOBIJANJE 7-/2-(5-AMINO-1,2,4-TIADIAZOL-3-IL)-2-(SUPSTITUISANI)IMINOACETAMIDO/-3 -/3-(KVATERNERNI AMONIO)-1-PROPEN-1-IL/-3-CEFEM-4-KARBOKSILATA formule: u kojoj je R1 vodonik ili amino-zaštitna grupa kao što je tricil; R2 je vodonik, C1-4alkil, C3-6cikloalkil, C3-6cikloalkenil ili grupa formule: gde je R3 vodonik, C1-4 alkil ili karboksi, X je halogen, OH ili C1-4alkoksi i R4 i R5 su svaki nezavisno vodonik, metil ili etil ili R4 i R5, zajedno sa ugljenikovim atomom za koji su vezani, grade C3-5 cikloalkilidenski prsten; i je kvaternerna amonio grupa, i njihovih netoksičnih farmaceutski prihvatljivih soli i estara koji hidrolizuju pod fiziološkim uslovima, naznačen time, što obuhvata reakciju jedinjenja formule: sa kiselinom formule: ili sa njenim aktiviranim derivatom, kao što je hlorid, pri čemu je kao što je definisano gore, R2 ima značenja kao što je definisano gor za R2, ili predstavlja grupu formule: gde su X, R4 i R5 kao što je definisano gore, B1 je karboksi-zaštitna grupa kao što je benzhidril ili t-butil i B2 je vodonik ili amino-zaštitna grupa kao što je tricil, u smeši vode i orgnaskog rastvarača kao što je aceton ili dimetilformamid i na temperaturi od -10 do +50 C, poželjno od +10 C do sobne temperature; što se, po potrebi, vrši uklanjanjem zaštitnih grupa reakcijom sa kiselinom kao što je HCl, i što se dobijeni proizvod formule (I), po potrebi, prevodi u svoju netoksičnu far-maceutski prihvatljivu so ili estar koji hidrolizuje pod fiziološkim uslovima. Prijava sadrži još 2 patentna zahteva.
YU118987A 1984-04-09 1987-06-25 Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata YU46213B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU118987A YU46213B (sh) 1984-04-09 1987-06-25 Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09
YU60085A YU46151B (sh) 1984-04-09 1985-04-09 Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata
YU118987A YU46213B (sh) 1984-04-09 1987-06-25 Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Publications (2)

Publication Number Publication Date
YU118987A YU118987A (en) 1988-10-31
YU46213B true YU46213B (sh) 1993-05-28

Family

ID=24393575

Family Applications (2)

Application Number Title Priority Date Filing Date
YU60085A YU46151B (sh) 1984-04-09 1985-04-09 Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata
YU118987A YU46213B (sh) 1984-04-09 1987-06-25 Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU60085A YU46151B (sh) 1984-04-09 1985-04-09 Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Country Status (31)

Country Link
JP (4) JPS615084A (sh)
KR (1) KR870002166B1 (sh)
AR (1) AR244694A1 (sh)
AT (1) AT388735B (sh)
AU (2) AU580990B2 (sh)
BE (1) BE902148A (sh)
CA (3) CA1276929C (sh)
CH (1) CH669197A5 (sh)
DD (3) DD249024A5 (sh)
DE (1) DE3512225A1 (sh)
DK (1) DK155985A (sh)
ES (4) ES8607318A1 (sh)
FI (1) FI84830C (sh)
FR (1) FR2563832B1 (sh)
GB (3) GB2157293B (sh)
GR (1) GR850883B (sh)
HU (2) HU193750B (sh)
IE (2) IE58408B1 (sh)
IL (1) IL74826A (sh)
IT (1) IT1190353B (sh)
LU (1) LU85840A1 (sh)
MY (1) MY101940A (sh)
NL (1) NL192925C (sh)
NZ (1) NZ211659A (sh)
OA (1) OA07985A (sh)
PT (1) PT80246B (sh)
RU (1) RU2056425C1 (sh)
SE (4) SE466205B (sh)
SU (4) SU1436882A3 (sh)
YU (2) YU46151B (sh)
ZA (1) ZA852236B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (ja) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd 新規セフエム化合物及びその製造法
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
DE3650157T2 (de) * 1985-12-26 1995-05-04 Eisai Co Ltd Cephalosporin-verbindungen.
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
JPH085897B2 (ja) * 1986-11-06 1996-01-24 エーザイ株式会社 ３−プロペニルセフェム誘導体
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
CN1022837C (zh) * 1988-03-16 1993-11-24 卫材株式会社 制备头孢烯衍生物的方法
JPH0699449B2 (ja) * 1988-03-16 1994-12-07 エーザイ株式会社 セフェム誘導体の合成中間体
FR2655042B1 (fr) * 1989-11-29 1994-01-21 Adir Cie Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
JPH0741484A (ja) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk セフェム化合物及び抗菌剤
US5661144A (en) * 1994-08-16 1997-08-26 Meiji Seika Kabushiki Kaisha Cephem derivatives with 3-substituted bis heterocycles
ID28433A (id) 1998-06-22 2001-05-24 Hoffmann La Roche Turunan propenil sefalosporin
JP4658806B2 (ja) 2003-09-09 2011-03-23 日本化学工業株式会社 ３−クロロメチル−３−セフェム誘導体の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (de) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathiaverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (sh) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (sh) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
YU118987A (en) 1988-10-31
CH669197A5 (de) 1989-02-28
FI84830B (fi) 1991-10-15
HU193750B (en) 1987-11-30
AU580990B2 (en) 1989-02-09
NL192925C (nl) 1998-05-07
YU60085A (en) 1987-12-31
FI84830C (fi) 1992-01-27
ES551551A0 (es) 1987-07-01
IE58403B1 (en) 1993-09-22
KR870002166B1 (ko) 1987-12-14
DD249024A5 (de) 1987-08-26
SE8901224L (sv) 1989-04-06
NZ211659A (en) 1988-11-29
YU46151B (sh) 1993-05-28
ATA103985A (de) 1989-01-15
SE8901225L (sv) 1989-04-06
SU1375140A3 (ru) 1988-02-15
JPS615084A (ja) 1986-01-10
PT80246B (pt) 1987-10-20
GB2194789A (en) 1988-03-16
IT1190353B (it) 1988-02-16
SE505256C2 (sv) 1997-07-21
IL74826A0 (en) 1985-07-31
JPS61143391A (ja) 1986-07-01
SE8901225D0 (sv) 1989-04-06
SU1367858A3 (ru) 1988-01-15
CA1340638C (en) 1999-07-06
AT388735B (de) 1989-08-25
SE8501680D0 (sv) 1985-04-03
DK155985A (da) 1985-10-10
ES542013A0 (es) 1986-06-16
DE3512225A1 (de) 1985-10-17
GB2194790B (en) 1988-10-05
FR2563832A1 (fr) 1985-11-08
AU610278B2 (en) 1991-05-16
PT80246A (en) 1985-05-01
IL74826A (en) 1990-01-18
AR244694A1 (es) 1993-11-30
JPS61143387A (ja) 1986-07-01
SU1487814A3 (ru) 1989-06-15
CA1276929C (en) 1990-11-27
GB8721346D0 (en) 1987-10-14
GR850883B (sh) 1985-11-25
ZA852236B (en) 1985-11-27
GB2194789B (en) 1988-10-12
NL8501002A (nl) 1985-11-01
JPH0262557B2 (sh) 1990-12-26
GB2194790A (en) 1988-03-16
ES557060A0 (es) 1987-12-01
ES8800949A1 (es) 1987-12-01
MY101940A (en) 1992-02-15
JPS61143390A (ja) 1986-07-01
BE902148A (fr) 1985-10-09
NL192925B (nl) 1998-01-05
FI851379L (fi) 1985-10-10
HUT37622A (en) 1986-01-23
OA07985A (fr) 1987-01-31
ES551550A0 (es) 1987-06-01
SE8901224D0 (sv) 1989-04-06
GB2157293B (en) 1988-10-05
JPH0351716B2 (sh) 1991-08-07
SE466205B (sv) 1992-01-13
AU4086285A (en) 1985-10-17
IT8520267A0 (it) 1985-04-05
GB8508846D0 (en) 1985-05-09
ES8607318A1 (es) 1986-06-16
DD236735A5 (de) 1986-06-18
LU85840A1 (fr) 1985-12-16
IE58408B1 (en) 1993-09-22
SU1436882A3 (ru) 1988-11-07
ES8706155A1 (es) 1987-06-01
FI851379A0 (fi) 1985-04-04
JPH0350754B2 (sh) 1991-08-02
ES8706694A1 (es) 1987-07-01
GB2157293A (en) 1985-10-23
GB8721347D0 (en) 1987-10-14
SE8501680L (sv) 1985-10-10
SE470260B (sv) 1993-12-20
AU2504188A (en) 1989-03-02
DK155985D0 (da) 1985-04-03
SE470259B (sv) 1993-12-20
CA1340672C (en) 1999-07-20
DD251752A5 (de) 1987-11-25
JPH0357106B2 (sh) 1991-08-30
FR2563832B1 (fr) 1989-08-18
HU204277B (en) 1991-12-30
KR850007424A (ko) 1985-12-04
IE850866L (en) 1985-10-09
DE3512225C2 (sh) 1990-02-22
SE8901226L (sv) 1989-04-06
RU2056425C1 (ru) 1996-03-20
SE8901226D0 (sv) 1989-04-06

Similar Documents

Publication Publication Date Title
YU46213B (sh) Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata
CA1085822A (en) Cephalosporin compounds
ES2026746A6 (es) Un procedimiento para la preparacion de tetrazoles.
ES2005746A6 (es) Un procedimiento para la preparacion de un haluro de piridinio.
ES8706144A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
PH25314A (en) New naphthyl derivatives, pharmaceutical compositions containing these compounds , their method of use
SU725553A3 (en) Method of preparing benzyl dichlorovinyldimethylcyclopropanecarboxylates
CA1052810A (en) .omega.-(N-ACYLAMINO) ALKYLPHOSPHORYL ETHANOLAMINES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USES
CS242088A2 (en) Method of 1-cyclopropyl-7-substituted-6-fluor-4-oxo-1,4-dihydroquinoline-3-carboxylic acid's derivatives production
HUT37431A (en) Process for the production of imidazo /1,2-c/pyrimidines and of their salts,as well as of therapeutic preparations containing these compounds as agent
ES8201959A1 (es) Procedimiento para preparar 3,3'-azo-bis-(acido 6-hidroxi- benzoico)
IL131177A (en) Process for the preparation of nicotinic acids and esters
YU46433B (sh) Postupak za dobijanje kondenzovanih derivata pirimidina
JPS54106430A (en) Novel preparation of lysophosphatidylcholine analog
NISHIGAKI et al. Synthetic Antibacterials. VI. 7-[1-Substituted 2-(5-nitro-2-furyl) vinyl]-1, 8-naphthyridines
ES8307233A1 (es) Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico.
ES8506606A1 (es) Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas
JPS5759896A (en) Production of thiazolineazetidinone derivative
JPS55145669A (en) 8,10-diazaprostanoic acid derivative and its preparation
ES8504698A1 (es) Procedimiento para preparar compuestos de azetidina.
JPS5527111A (en) Preparation of cephapirin
SE8501540D0 (sv) Timololmellanprodukter
JPS57144264A (en) 6-fluoro-1,4-dihydro-4-oxocinnoline-3-carboxylic acid derivative
JPS58174374A (ja) チアゾリジン誘導体
JPS559034A (en) Penem derivative and its preparation